厄洛替尼

厄洛替尼（，商品名：Tarceva，特罗凯）是用于治疗（NSCLC）、胰腺癌等几种癌症的药物，作为一种酪氨酸激酶抑制剂作用于表皮生长因子受体，由罗氏公司生产。

藥物合成
第一種合成路徑

第二種合成路徑

参考文献

外部链接
Official Tarceva website 
Tarceva Discussion Group for Cancer Patients 
.
 Genzyme "Genzyme Launches Exclusive Lung Cancer Test" Press Release September 27, 2005
 "Determinants of Tumor Response and Survival With Erlotinib in Patients With Non-Small-Cell Lung Cancer , Journal of Clinical Oncology, August 15, 2004.
 October 2003 issue of Lung Cancer Frontiers on rash/effectiveness correlation
 FAQ: I started an EGFR inhibitor two weeks ago but haven’t developed a rash. Does this mean it’s not working?, Dr. Howard L. (Jack) West, M.D., GRACE, February 21, 2011 (directed toward the layperson).
http://www.cancer.gov/clinicaltrials/results/lung-and-erlotinib0604l
https://web.archive.org/web/20081012081613/http://www.roche.com/med-cor-2007-10-22
https://web.archive.org/web/20110726060413/http://www.roche.com/med-cor-2009-05-30b
https://web.archive.org/web/20120918193637/http://www.cipla.com/whatsnew/news.htm#27apr09
https://web.archive.org/web/20120918193637/http://www.cipla.com/whatsnew/news.htm#20mar08

胺
苯醚
苯乙炔
喹唑啉
受体酪氨酸激酶抑制剂
世界卫生组织基本药物